Skip to main content
Journal cover image

Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure: insights from the ARISTOTLE trial

Publication ,  Conference
Rordorf, R; De Ferrari, GM; Wojdyla, D; De Caterina, R; Thomas, L; Granger, CB; Leonardi, S; Alexander, JH; Wallentin, L; Lopes, RD
Published in: EUROPEAN HEART JOURNAL
August 1, 2015

Duke Scholars

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

August 1, 2015

Volume

36

Start / End Page

1068 / 1068

Location

London, ENGLAND

Publisher

OXFORD UNIV PRESS

Conference Name

Congress of the European-Society-of-Cardiology (ESC)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Rordorf, R., De Ferrari, G. M., Wojdyla, D., De Caterina, R., Thomas, L., Granger, C. B., … Lopes, R. D. (2015). Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure: insights from the ARISTOTLE trial. In EUROPEAN HEART JOURNAL (Vol. 36, pp. 1068–1068). London, ENGLAND: OXFORD UNIV PRESS.
Rordorf, R., G. M. De Ferrari, D. Wojdyla, R. De Caterina, L. Thomas, C. B. Granger, S. Leonardi, J. H. Alexander, L. Wallentin, and R. D. Lopes. “Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure: insights from the ARISTOTLE trial.” In EUROPEAN HEART JOURNAL, 36:1068–1068. OXFORD UNIV PRESS, 2015.
Rordorf R, De Ferrari GM, Wojdyla D, De Caterina R, Thomas L, Granger CB, et al. Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure: insights from the ARISTOTLE trial. In: EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 1068–1068.
Rordorf, R., et al. “Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure: insights from the ARISTOTLE trial.” EUROPEAN HEART JOURNAL, vol. 36, OXFORD UNIV PRESS, 2015, pp. 1068–1068.
Rordorf R, De Ferrari GM, Wojdyla D, De Caterina R, Thomas L, Granger CB, Leonardi S, Alexander JH, Wallentin L, Lopes RD. Digoxin use is associated with higher mortality among patients with atrial fibrillation with and without heart failure: insights from the ARISTOTLE trial. EUROPEAN HEART JOURNAL. OXFORD UNIV PRESS; 2015. p. 1068–1068.
Journal cover image

Published In

EUROPEAN HEART JOURNAL

EISSN

1522-9645

ISSN

0195-668X

Publication Date

August 1, 2015

Volume

36

Start / End Page

1068 / 1068

Location

London, ENGLAND

Publisher

OXFORD UNIV PRESS

Conference Name

Congress of the European-Society-of-Cardiology (ESC)

Related Subject Headings

  • Cardiovascular System & Hematology
  • 3202 Clinical sciences
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology